The current study included all available plasma samples from women who met our inclusion criteria (n = 1115 plasma samples, n = 326 women). Maternal peripheral plasma samples were collected in EDTA and stored at −80 °C unthawed until testing. Plasma samples were processed using enzyme-linked immunosorbent assays (Duosets, R&D Systems, Minneapolis, MN) listed with dilution factors: CHI3L1 (1:1000), CRP (1:8000), IL-18BP (1:20), IL-6 (1:20), sICAM-1 (1:500), and sTNFR2 (1:200). The markers were selected based on previous studies reporting an association with MiP and PTB20 (link),24 (link),35 (link). Processing and analysis of samples was performed according to the manufacturer’s instructions and blinded to treatment group and outcome.
Free full text: Click here